Photoacoustic Imaging Market Size Worth USD 175.8 Million By 2027 | CAGR of 15.2%: Emergen Research

VANCOUVER, BC, Oct. 19, 2020 /PRNewswire/ -- The Global Photoacoustic Imaging Market will be worth USD 175.8 million by 2027, according to a current analysis by Emergen Research. It is also known as optoacoustic imaging, which can be defined as a hybrid imaging technique with a high potential in clinical biomedical application areas as well as multi-scale preclinical matters. It is considered one of the rapidly developing biomedical imaging modalities of the decade, providing sustainable imaging resolution and depth, along with optical spectroscopic contrast, thereby making it an ideal solution for real-time functional, structural, and molecular imaging of tissue.

Emergen Research Logo

Biomedical PA imaging is currently at a rising stage of clinical translation, and it is of utter importance for research institutions as well as academic establishments to make portable and affordable delivery and detection solutions to expand smoother transition to the clinic. The issue helps to address a wide spectrum of PA imaging techniques, primarily targeting the latest advances in light sources, along with their delivery methods, which makes detection strategies to help maintain affordable PA imaging solutions.

Currently, PA imaging has also extended to biomedical and medical markets. The major segments are namely clinical (early stage diagnosis), preclinical (drug efficiency monitoring on small animal), and analytics (flow cytometry and microscopy for in vitro diagnosis). In 2019, the total PAI biomedical and medical market was valued at nearly USD 36.5 million, because of the analytics and preclinical segments. According to our analysts, it is forecast to touch USD 241 million by 2022. A steep increase has been witnessed in the growth curve since 2018, mainly because of the launch of clinical products that were approved in 2017, like the Imagio system from Seno Medical Instruments, U.S. The primary application areas that are likely to benefit from clinical products are cardiovascular diagnostics, cancer research, brain imaging, therapy monitoring, dermatology, and drug developments.

Request free sample of this research report at:

Key Highlights From The Report.

  • In June 2020, Fujifilm VisualSonics Inc., a subsidiary of FUJIFILM SonoSite, Inc., launched the first of its kind ultra-high to low-frequency ultrasound imaging system equipped with a frequency range from 71-1 MHz. With an open and configurable architecture, this product is specifically targeted towards the scientific research community.
  • The prevalance of chronic disorders like cardiovascular diseases and cancer is pressing the utilization of real-time and non-invasive diagnostic methods for detection. As opposed to conventional ultrasound, the technology is emerging as a crucial diagnostic approach for detecting as well as managing chronic disorders easily. This is mainly because of its efficiency in the functional characterization of living tissues. The growing demand for PA Imaging is increasing in both clinical and preclinical research favorably for the initial detection of cancer as well as the abnormalities in cardiovascular diseases and microcirculation.
  • Attributing to the recent technological advancements, existing and emerging players in the market are also developing and offering innovative photoacoustic imaging solutions. Furthermore, because of the potential usage in humans, several ongoing research studies aim to develop new clinical photoacoustic imaging solutions.
  • The Photoacoustic Imaging Market in the North American region held the highest market share in 2019 and is likely to continue its dominance over the coming years. Over the years, Europe is likely to embrace the leading position in the market, which can be attributed to the installation of innovative and technology heavy gadgets with greater precision. The Asia Pacific region is also estimated to consider a significant market share and forecast to grow at a CAGR of about 15.9% because of the rising number of people with cardiovascular and neurological ailments.
  • Key participants include illumiSonics Inc., Seno Medical Instruments Inc InnoLas Laser GmbH, FUJIFILM VisualSonics Inc., kibero, iThera Medical GmbH, PhotoSound Technologies Inc., PA Imaging, and Teem Photonics, among others.

To get leading market solutions, visit the link below:

For the purpose of this report, Emergen Research has segmented the Global Photoacoustic Imaging Market on the product, end user, application, and region:

  • Product Outlook (Revenue, USD Billion; 2017-2027)
    • Imaging Systems
    • Lasers
    • Transducers
    • Contrast Agents
    • Software
  • End User Outlook (Revenue, USD Billion; 2017-2027)
    • Research Institutions
    • Hospitals and Clinics
  • Application Outlook (Revenue, USD Billion; 2017-2027)
    • Oncology
    • Cardiology
    • Neurology
    • Hematology
    • Others

Order Now:

  • Regional Outlook (Revenue: USD Billion; 2017-2027)
    • North America
      1. U.S.
      2. Canada
      3. Mexico
    • Europe
      1. U.K.
      2. Germany
      3. France
      4. BENELUX
      5. Rest of Europe
    • Asia Pacific
      1. China
      2. Japan
      3. South Korea
      4. Rest of APAC
    • Latin America
      1. Brazil
      2. Rest of LATAM
    • Middle East & Africa
      1. Saudi Arabia
      2. UAE
      3. Rest of MEA

Find more similar research insights by Emergen Research:

Bioremediation Market By Services (Soil, Wastewater and Oilfield Remediation, Others), By Technology (Phytoremediation, Biostimulation, Bioaugmentation, Bioreactors, Fungal Remediation, Land-Based Treatments) and By Regions Forecasts to 2027

Electrosurgical Devices Market By Method (Bipolar, Monopolar), By Product (Active electrodes, Electrosurgical Generators, Electrosurgical Instruments and Accessories), By Surgery Type (General surgery, Cosmetic, Cardiovascular), Forecasts to 2027

Prefilled Syringes Market By Type (Reusable, Disposable), By Material (Plastic, Glass), By Application (Diabetes, Rheumatoid Arthritis, Anaphylaxis, Cancer), By Distribution Channel (Ambulatory Surgery Centers, Hospitals, Mail Order Pharmacies), Forecasts to 2027

Inhalation and Nasal Spray Market By Application (Asthma, COPD, Allergic Rhinitis, Others), By Drug Type (Corticosteroids, Bronchodilators, Antihistamines, Decongestant Sprays, Others) and By Regions Forecasts to 2027

Depression Treatment Market By Drug Type (Antidepressants, Antipsychotics) By Application (Major Depressive Disorder (MDD), Bipolar Disorder), By End-User (Hospitals, NGOs, Mental Health Centers), By Distribution Channel, and By Region, Forecasts to 2027

About Emergen Research

At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

With market-leading insights and an in-depth understanding of leading and niche technologies, our solutions address the most pertinent questions for your business needs. A major technological shift has been witnessed towards creating a 'Circular Economy,' fuelled by factors, such as the increased adoption of bio-based materials, along with other methods for achieving carbon neutrality. We are conversant in technologies, viz., Artificial Intelligence (AI), Augmented Reality (AR), Virtual Reality (VR), Robotic Process Automation (RPA), Smart Manufacturing, Internet of Things (IoT), Big Data Analytics, Machine learning, Nanotechnology, Edge Computing, Blockchain Technology, Cloud Computing, Vehicle Electrification, Advanced Maintenance Analytics, and Predictive Maintenance, among other prevalent and emergent technologies.

Contact Us:

Eric Lee
Corporate Sales Specialist
Emergen Research | Web:
Direct Line: +1 (604) 757-9756

Read full Press Release at:


Cision View original content:

SOURCE Emergen Research

News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.